Ancora Advisors’s Editas Medicine EDIT Stock Holding History

Ancora Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-75	Closed	-$544	–	1826
2023 Q1	$544	Sell	75 -325	-81%	-$2.89K	﹤0.01%	1718
2022 Q4	$4K	Hold	400	–	–	﹤0.01%	1494
2022 Q3	$5K	Hold	400	–	–	﹤0.01%	1640
2022 Q2	$5K	Hold	400	–	–	﹤0.01%	1756
2022 Q1	$8K	Hold	400	–	–	﹤0.01%	1798
2021 Q4	$11K	Sell	400 -200	-33%	-$6.88K	﹤0.01%	1759
2021 Q3	$25K	Hold	600	–	–	﹤0.01%	1406
2021 Q2	$34K	Hold	600	–	–	﹤0.01%	1203
2021 Q1	$25K	Sell	600 -100	-14%	-$5.7K	﹤0.01%	1239
2020 Q4	$49K	Sell	700 -100	-13%	-$4.11K	﹤0.01%	883
2020 Q3	$22K	Hold	800	–	–	﹤0.01%	999
2020 Q2	$24K	Buy	800 +400	+100%	+$10.5K	﹤0.01%	964
2020 Q1	$8K	Buy	+400	New	+$10.1K	﹤0.01%	1217
2018 Q4	–	Sell	-4,000	Closed	-$127K	–	766
2018 Q3	$127K	Buy	+4,000	New	+$129K	﹤0.01%	711

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Ancora Advisors's EDIT Position: Q2 2023 in Review

Ancora Advisors sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 75 shares — an estimated $544 sold.

Ancora Advisors first reported a position in EDIT in Q3 2018 and held it in 14 quarters. The position peaked at $127K in Q3 2018. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

Ancora Advisors reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
Ancora Advisors sold 75 Editas Medicine shares in Q2 2023, an estimated $544.
Ancora Advisors first reported a position in Editas Medicine in Q3 2018 and held it in 14 quarters.
Ancora Advisors's Editas Medicine position peaked at $127K in Q3 2018.
237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.